Upcoming Medical Policies
BlueCross BlueShield of Tennessee

Each medical policy listed below will become effective on the date indicated, and will be included in the Medical Policy Manual for BlueCross BlueShield of Tennessee on that effective date.

Medical policies are developed using an evidence-based evaluation process.  The medical evidence used in this process comes from several sources, including independent medical technology review organizations, the peer reviewed medical literature, and opinions from appropriate network specialists. All Medical Policies are reviewed by a panel of internal and external physicians before being adopted by the company.

Topics due to be included in the Medical Policy Manual on 11/8/2014

Topics due to be included in the Medical Policy Manual on 11/19/2014

Topics due to be included in the Medical Policy Manual on 12/13/2014

Topics due to be included in the Medical Policy Manual on 12/17/2014

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Topics due to be included in the Medical Policy Manual on 11/8/2014:

Multi-biomarker Testing for Rheumatoid Arthritis

Topics due to be included in the Medical Policy Manual on 11/19/2014:

Ado-Trastuzumab Emtansine

Certolizumab Pegol

Genetic Testing, Including Chromosomal Microarray Analysis and Next-Generation Sequencing Panels, for Prenatal Evaluation and Evaluation of Children with Developmental Delays/Intellectual Delays or Autism Spectrum Disorder

Proton or Helium Ion Beam (Charged Particle) Radiation Therapy

Topics due to be included in the Medical Policy Manual on 12/13/2014:

Molecular Panel Testing of Cancers to Identify Targeted Therapies

Topics due to be included in the Medical Policy Manual on 12/17/2014:

Brentuximab Vedotin


Last Review Date: 10/14/2014

 

Medical Policy Comments:

Please reference the policy name or tracking number in your comments.
To submit comments about the upcoming Medical Policies:
Click the “Medical Policy Comments” above or click here: Comments or Feedback.

Comments can also be mailed to:

BlueCross BlueShield of Tennessee
Medical Policy
1 Cameron Hill Circle
Chattanooga, TN 37402